SCIB — SciBase Holding AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK182.78m
- SEK168.83m
- SEK40.46m
Brief: Scibase Holding Q2 Loss After Tax Widens To SEK 11.2 Million
Brief: SciBase Raises SEK 71.2 Mln Through Two Directed Issues
Brief: Scibase Holding AB (Publ) - Q1 Loss After Tax Amounted To Tsek 8,153
Brief: SciBase Gets European MDR Certification
Brief: SciBase Study Shows Nevisense Potential For Assessment Of Skin Barrier
Brief: SciBase: Study Supports Use Of Nevisense Within New Non-Melanoma Skin Cancer Application
Brief: Scibase Q3 Loss Narrwos To SEK 7.4 Mln
Brief: SciBase Holding: Positive Step For US reimbursement Of Nevisense
Brief: Scibase Holding: Outcome Of Exercise Of Warrants Of Series TO1
Brief: SciBase Holding: Exercise Price For Exercise Of Warrants Determined To SEK 1.75
Brief: SciBase Holding Updates On New Clinical Studies Of Nevisense
Brief: SciBase Holding Q2 Loss After Tax Narrows To SEK 8.9 Mln
Brief: SciBase Holding: Nevisense To Be Included In Clinical Study At NYU Langone Health
Brief: SciBase Holding Begins Rollout Of Nevisense Technology in Florida
Brief: SciBase Submits Reimbursement Application
Brief: SciBase Rights Issue Heavily Oversubscribed
Brief: Scibase Q1 Loss After Tax At SEK 8.9 Mln
Brief: SciBase Receives FDA Approval For Nevisense 3.0
Brief: SciBase, Advanced Dermatology And Cosmetic Surgery Group In Partnership